Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/23/2003EP1303258A1 Novel aerosol formulation containing a polar fluorinated molecule
04/23/2003EP1303252A1 Composition comprising a ceramide precursor for improving natural or reconstructed epidermis, resulting skin equivalent
04/23/2003EP1303251A1 Composition, in particular cosmetic, containing dhea and/or a chemical or biological precursor or derivative thereof, and a metalloproteinase inhibitor
04/23/2003EP1303249A1 Antimycotic nail varnish composition
04/23/2003EP1303245A1 Composition for topically delivering vitamin c
04/23/2003EP1303192A1 Dietary lipids for improving skin and coat of pets
04/23/2003EP1257537A4 Therapeutic morpholino-substituted compounds
04/23/2003EP1254131A4 Extraction of flavonoids
04/23/2003EP1242445B1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds
04/23/2003EP1242009A4 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds
04/23/2003EP1237892B1 Method for producing epinastine hydrochloride in the high-melting crystal modification
04/23/2003EP1222183B1 Benzopyran derivatives
04/23/2003EP1220863B1 Purine derivatives
04/23/2003EP1218378B1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives
04/23/2003EP1196050B1 Compositions for providing and maintaining energy and mental alertness
04/23/2003EP1185257A4 Treatment of acne using lipoic acid
04/23/2003EP1175428B1 3-deoxy-desmycosin derivatives and process for their preparation
04/23/2003EP1158925A4 Methods for treating superficial bladder carcinoma
04/23/2003EP1154794B1 Treatment of symptoms of parkinson's disease with an agent comprising a dopaminergic substance and a local anaesthetic of the anilide group
04/23/2003EP1146862B1 Pharmaceutical compositions
04/23/2003EP1140925B1 (3,4 dihydro-2h-benzo[1,4] oxazinyl-methyl)- 3-(1h-indol-3- yl)-alkyl -amines
04/23/2003EP1133483B1 Il-5 inhibiting 6-azauracil derivatives
04/23/2003EP1131072B1 Pharmaceutical combination preparations in solid dosage form of carvedilol and hydrochlorothiazide
04/23/2003EP1131063B1 Hyperforin ointment or cream
04/23/2003EP1121102B1 Liposome-entrapped topoisomerase inhibitors
04/23/2003EP1114046B1 Interleukin-5 inhibiting 6-azauracil derivatives
04/23/2003EP1107744B1 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia
04/23/2003EP1105109B1 Injectable formulations of nanoparticulate naproxen
04/23/2003EP1102739B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
04/23/2003EP1100488B1 Use of creatine compounds for treatment of bone or cartilage cells and tissues
04/23/2003EP1098966A4 Methods for purifying nucleic acids
04/23/2003EP1094807B1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies
04/23/2003EP1093450B1 Desformoterol and process for its preparation
04/23/2003EP1082314B1 New dipeptidyl peptidase iv effectors
04/23/2003EP1077975B1 Water soluble azoles as broad-spectrum antifungals
04/23/2003EP1063230B1 Cyclic amino compounds
04/23/2003EP1060183B1 5'-deoxycytidine derivatives
04/23/2003EP1057033B1 Treating cancer
04/23/2003EP1057032B1 Treating cancer
04/23/2003EP1057031B1 Treating cancer
04/23/2003EP1057030B1 Treating cancer
04/23/2003EP1057029B1 Treating cancer
04/23/2003EP1057028B1 Treating cancer
04/23/2003EP1054913B1 Method for the production of polymers from n-vinyl compounds
04/23/2003EP1051387B1 Anticancer platinum (iv) complexes for oral administration
04/23/2003EP1047406B1 Autoclavable pharmaceutical compositions containing a chelating agent
04/23/2003EP1045851B1 Substituted porphyrins
04/23/2003EP1045830B1 Alpha-aminoamide derivatives useful as analgesic agents
04/23/2003EP1045690B1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
04/23/2003EP1042277B1 Naphthalene derivatives
04/23/2003EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
04/23/2003EP1028962B1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
04/23/2003EP1027359B1 Monocyclic l-nucleosides, analogs and uses thereof
04/23/2003EP1020474B1 Oligosaccharide derivatives and process for producing the same
04/23/2003EP1017363B1 Taste masking for unpalatable formulations
04/23/2003EP1009397B1 Use of n,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of chronic pain
04/23/2003EP1007032B1 4-cyano-4-deformylsordaricin derivatives
04/23/2003EP1003764B1 Improved process for preparing antiparasitic agent
04/23/2003EP1001924B1 The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
04/23/2003EP0993442B1 Hydrazine derivatives
04/23/2003EP0984975B1 Multicyclic erythromycin derivatives
04/23/2003EP0977767A4 Aminooxy-modified oligonucleotides
04/23/2003EP0956022B1 Hormonal composition consisting of an oestrogen compound and of a progestational compound
04/23/2003EP0948265B1 A method to prepare food seasoning, food ingredient and food item compositions, seasoning and use thereof
04/23/2003EP0946584B1 Meiosis regulating compounds
04/23/2003EP0941085B1 Device for electrically assisted delivery of agents such as lidocaine and epinephrine
04/23/2003EP0937083B1 A crystalline substance of cefditoren pivoxil and the production of the same
04/23/2003EP0937041B1 Use of a pharmaceutically acceptable salt of (3R,2'R)-3-[(Cyclopently-hydroxyphenylacetyl)oxy]-1,1-dimethyl-pyrrolidinium for the preparation of a medicament
04/23/2003EP0910379B1 Plaster for the transdermal application of pergolide
04/23/2003EP0893951A4 METHODS OF MODULATING RADICAL FORMATION BY MUTANT CuZnSOD ENZYMES
04/23/2003EP0889881B1 New triazoles as therapeutic agents for fungal infections
04/23/2003EP0873315B1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
04/23/2003EP0873134B1 Aqueous prolonged release formulation comprising bovine growth hormone-releasing factor
04/23/2003EP0861266B1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them
04/23/2003EP0859599B1 Liposomal formulations of mitoxantrone
04/23/2003EP0854723B1 Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies as antiinflammatory agents
04/23/2003EP0853472B1 Use of carbohydrates for promoting skin exfoliation
04/23/2003EP0844999B1 Purification process
04/23/2003EP0836615B1 New thrombin inhibitors, their preparation and use
04/23/2003EP0831825B1 Pharmaceutical formulations of highly lipophilic camptothecin derivatives
04/23/2003EP0797443B1 A pharmaceutical composition with improved bio-availability of inositol phosphate
04/23/2003EP0795025B1 Enantioselective preparation of pharmaceutically active sulfoxides by bioreduction
04/23/2003EP0794780B1 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
04/23/2003EP0788373B1 Novel complexes of taxol or taxotere and pharmaceutical compositions
04/23/2003EP0787725B1 Quinoline derivative
04/23/2003EP0764021B1 Uterine fibroid treatment
04/23/2003EP0699072B1 Use of iron-binding polymers for the manufacture of a medicament for oral administration
04/23/2003EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor
04/23/2003CN1413258A Invasive bacterial vectors for expressing alphavirus replicons
04/23/2003CN1413249A Human heparanase-related polypeptide and nucleic acid
04/23/2003CN1413220A Anti-prostate stem cell antigen (PSCA) antibody compositions and method of use
04/23/2003CN1413216A Azolyalkyl-oxa (di) azolyl pyri (mi) dine derivatives, method for their production and use as pesticides
04/23/2003CN1413213A Azaindoles
04/23/2003CN1413211A Substituted 1,3,4-oxadiazoles and method of producing TNF-alpha levels
04/23/2003CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/23/2003CN1413208A Novel derivatives of 3-imino-1,2,-dithioles, method for producing them and pharmaceutical compositions containing the same
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/23/2003CN1413206A Non peptide tachykinin receptor antagonists
04/23/2003CN1413205A 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity
04/23/2003CN1413198A Methods and compositions utilizing quianzolinones
1 ... 5493 5494 5495 5496 5497 5498 5499 5500 5501 5502 5503 5504 5505 5506 5507 5508 5509 5510 5511 5512 5513 ... 7860